Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chi-BEAM vs BEAM in Newly Diagnosed PTCL
NCT05931263Phase 3Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by Jiangsu Provincial People's Hospital. Started Jun 2023; status: recruiting.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT05931263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05931263.